NIH Strengthening Enforcement of Grant Closeout Requirements
In a recent issue of Extramural Nexus, NIH's Deputy Director for Extramural Research, Mike Lauer, writes that: "Just as we strive to award meritorious grants as quickly as we can, it is equally important for us to ensure grant awards are taken off the books in a timely manner." He notes that: "A grant that slips past its closeout due date is costly and time consuming."

To that end, NIH recently issued an NIH Guide notice (NOT-OD-18-107) informing the community that it will initiate unilateral closeout-i.e. closeout without receipt of acceptable final reports-for all awards failing to meet closeout requirements within 120 calendar days. 

Know these five important facts:
  • Each awardee must submit a Final Federal Financial Report (FFR) (SF425) after each phase I and phase II project closes.
  • Non-compliance may affect future funding.
  • Non-compliance is expensive both for the company and for the tax payers.
  • Last year NIH took action and unilaterally closed over 5,000 grants.
  • Awardees may submit a request for an extension to file beyond the 120 days.
DOD and DOE Updates
Lockheed Martin (LM) has released a listing of DOD SBIR 2018.1, STTR 2018.A solicitation topics of interest to LM personnel. The listing helps connect companies with the LM technical points of contacts to explore opportunities for partnership and innovation. View list

Approximately every three years, the Advanced Research Projects Agency-Energy (ARPA-E) issues OPEN funding opportunity announcements as a means to address the full range of energy-related technologies. A broad variety of projects will be welcomed, including electricity generation by both renewable and non-renewable means; electricity transmission, storage, and distribution; energy efficiency for buildings, manufacturing and commerce, and personal use; and all aspects of transportation. Concept papers due Feb. 12, 2018. More info

The ARPA-E Summit will be held March 13-15, 2018 in Washington, DC. The Summit offers a three-day program aimed at showcasing transformational energy technologies. More info

Add This to Your New Year's Resolutions
A Riddle: What takes longer than anyone ever expects? Is insidiously difficult even for the most highly educated people? Will REGISTER NOW sabotage your SBIR/STTR submission in the final hours? When incorrectly done is never your fault but is in fact almost always your fault?

Answer:  Registrations to submit SBIR/STTR proposals!
It never fails. No matter how much we beg, plead and cajole, we still have companies that start the process too late and/or don't pay enough attention to the details (and there are many!). The ramifications? Failure to submit!

Therefore we ask that you add just one more resolution to your 2018 list. Do it right! Start early. Worry about details.

Remember:  E very agency has its own requirements, typically involving multiple individual registrations. So  start the year off right. Check out BBCetc's Registration Requirements page which includes a convenient table highlighting the various registration requirements of all the agencies. The agency names and registration types are hyperlinked to help you find the relevant information. Still confused?? If so don't hesitate to contact us (WITH PLENTY OF TIME BEFORE THE DEADLINE) and we'll be happy to help.

Look Into iCorps Programs
Have a great technology concept? Want to commercialize it?
The NYC Regional Innovation Node (NYCRIN) is currently launching a new SBIR Phase 0 program. Its goals are to identify and improve the preparation of potential applicants to the NSF Small Business Innovation Research (SBIR) Phase I program.  What is the SBIR Phase 0 Program?  The SBIR Phase 0 program will support eligible Phase 0 teams and existing companies to participate in a 7-week national Innovation Corps (I-Corps) cohort. Read the FAQ

Neat Tech
ONL Therapeutics (ONL) is a biopharmaceutical company committed to protecting and improving the vision of patients with a range of retinal disease and conditions. By advancing a breakthrough technology designed to prevent the death of key retinal cells caused by the activation of the natural Fas pathway, ONL is pioneering an entirely new approach to preserving sight. It is the first and only company focused on preventing Fas-mediated death of key retinal cells, which is a root cause of vision loss, a leading cause of blindness and a completely unaddressed medical need. 
More Funding Opportunities

Posted/Due Date
Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)
Posted: 12/19/17
Open: 3/5/18
Due: Standard due dates

BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44 Clinical Trial Not Allowed)

Posted: 12/15/17
Open: 3/5/18
Due: Standard due dates

Non-Invasive Diagnostics to Improve Gynecologic Health (R43/R44 - Clinical Trial Optional)
Posted: 12/14/17
Open: 2/28/18
Due: 3/30/18

Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) 
Posted: 12/21/17 Open: 2/21/18
Due: 2/21/18

Lab to Marketplace: Tools for Brain and Behavioral Research (R43/R44 - Clinical Trial Optional)
Posted: 1/9/18
Open: 3/5/18
Due: Standard dues dates

monkey 2
Aw, Shucks
"I am not a seasoned Grant Writer, but dove into an SBIR for a terrific product as the COO of SynchroPET. BBC's constant planning, and goading, webinars, and review of progress made it possible for us to prepare a modern Small Business grant application with the NIH. They floated foreign terms like eRA Commons, Sub Award, and the best, ASSIST, past me and I grabbed on and learned.

"SynchroPET had submitted previously (unsuccessfully) and some in our crew insisted I use the legacy method that is valid for this time only. Then Kris yelled at me to use ASSIST or else... The validated application alone is worth the price of admission, even if it weren't the only method accepted going forward. In addition to BBC's detailed advice on our applications formatting and content, the ability of ASSIST to tell me when we had a show stopper, or could even do it better, was crucial." 

Tom Mariner, COO, SynchroPET

who we are
BBCetc is nationally recognized for its expertise in helping technology-based entrepreneurs win federal funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs and use it strategically to propel growth.  BBCetc capabilities include:
  • Commercialization planning
  • Research grant assistance
  • SBIR/STTR training and proposal development assistance
  • Grants/contracts management
  • Tech-based economic development programs
Contact us:  / 734.930.9741

Copyright ©  BBC Entrepreneurial Training & Consulting LLC
QuizTime Answers:
1.  False, proposals must respond to a specific topic
3. A, C, F

Get them all?       No? Next time!
  training on tap
SBIR/STTR Proposal Prep for NIH   
Jan 18 - Plymouth, MI
Jan 18 - Stony Brook, NY
Feb 13-14 - Charlottesville, VA
Feb 28 - Seattle, WA

The ABC's of SBIR/STTR Funding 
Jan 25 - Ann Arbor, MI

SBIR/STTR Grant Writing Workshop
Jan 30-31 - Chicago, IL
Feb 12-13 - St. Louis, MO

SBIR/STTR 101 and Building a Quality Team
Feb 1 - Hammond, IN

Preparing a Budget for Your SBIR/STTR Proposal
Feb 9  E. Lansing, MI

SBIR/STTR Essentials-DOD and DOE
Feb 20 - Dallas, TX

Commercialization Planning for SBIR/STTR-Stage Cos.
Feb 22 Ann Arbor, MI

BBCetc's SBIR/STTR Pursuit webinar library

  HHS Omnibus  
The 2018 Omnibus grant solicitations of the NIH, CDC, and FDA are now available for the SBIR and STTR (NIH only) programs. This issuance also implements new NIH Clinical Trials Policy and FORMS-E transition.

Applicants can no longer submit directly to with a single, downloaded PDF form package. Submission options are:

> NIH ASSIST recommended
Your own System-to-System  solution

NIH is launching a series of initiatives to enhance the accountability and transparency of clinical research. These initiatives target key points along the whole clinical trial lifecycle from concept to results reporting. Learn more

The solicitations:
Clinical Trails not allowed:
PA-18-574 PHS 2018-02 SBIR for NIH, CDC & FDA
PA-18-575 PHS 2018-02 STTR for NIH
Clinical Trials allowed:
PA-18-573 PHS 2018-02 SBIR for NIH
PA-18-576 PHS 2018-02 STTR for NIH

Four due dates: Apr. 5, Sept. 7 (5th is a Sat.), 2018, and Jan. 5 and Apr. 5, 2019

Upcoming Webinars:
Feb. 6, 2-4PM ET - Clinical Trials Register
Feb. 7 2-4PM ET -         Non-Clinical Trials Register

Dept. of Defense (DOD)
Closes Feb. 7

Dept. of Energy
Closes Feb. 26  

Nat'l Oceanic/Atmospheric Administration (DOC)
Closes Jan. 31

Dept. of Education (DoEd)
Closes Jan. 25

Dept. of Transportation (DOT)
Opens Jan. 17; closes Mar. 20

Nat'l. Aeronautics and Space Admin. (NASA)
Opens Jan. 11; closes Mar.9

With DOE's SBIR/STTR Ph I Release 2 closing on Feb. 26, we decided to put our DOE whiz, Jerry Hollister, in charge of QuizTime this month. See if you can answer Jerry's posers!

1.  The DOE SBIR/STTR Program accepts proposals on any topic that relates to energy efficiency?
a) True
b) False

2. A company may submit up to how many proposals to the DOE SBIR/STTR Program per year?
a)  10 proposals per year
b)   10 proposals for Release 1, and 10 for Release 2
c)  The number of Letters of Intent approved by Technical Points of Contact
d)  As many as a company can reasonably complete prior to the deadline
e)  5 proposals for Release 1, and 5 for Release 2

3. Which of the following statements are true regarding the DOE SBIR/STTR Program?
a)  A Letter of Intent is required prior to submitting a Phase I proposal
b)  Any company can submit a Phase II proposal
c) The Principal Investigator for a STTR proposal may be employed by the partnering Research Institute
d)   Submissions of proposals are sent by email to the Technical Point of Contact listed for each Topic/SubTopic
e)   Proposals for Topics from Release 1 can be submitted up to the deadline for Release 2
f)  Companies can submit to both SBIR and STTR with the same proposal

Answers below left. No cheating!